Literature DB >> 27312054

SPAG5: the ultimate marker of proliferation in early breast cancer?

François Bertucci1, Patrice Viens2, Daniel Birnbaum3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27312054     DOI： 10.1016/S1470-2045(16)30092-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  7 in total

1.  Association of Sperm-Associated Antigen 5 and Treatment Response in Patients With Estrogen Receptor-Positive Breast Cancer.

Authors:  Tarek M A Abdel-Fatah; Graham R Ball; Pulari U Thangavelu; Lynne E Reid; Amy E McCart Reed; Jodi M Saunus; Pascal H G Duijf; Peter T Simpson; Sunil R Lakhani; Lorinc Pongor; Balázs Gyorffy; Paul M Moseley; Andrew R Green; Alan G Pockley; Carlos Caldas; Ian O Ellis; Stephen Y T Chan
Journal:  JAMA Netw Open       Date:  2020-07-01

2.  SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.

Authors:  Ming Li; Anqi Li; Shuling Zhou; Hong Lv; Wentao Yang
Journal:  J Hematol Oncol       Date:  2019-02-08       Impact factor: 17.388

3.  The prognostic association of SPAG5 gene expression in breast cancer patients with systematic therapy.

Authors:  Chenjing Zhu; Otilia Menyhart; Balázs Győrffy; Xia He
Journal:  BMC Cancer       Date:  2019-11-05       Impact factor: 4.430

4.  SPAG5 Is Involved in Human Gliomagenesis Through the Regulation of Cell Proliferation and Apoptosis.

Authors:  Chunhong Wang; Haiyang Su; Rui Cheng; Hongming Ji
Journal:  Front Oncol       Date:  2021-11-02       Impact factor: 6.244

5.  CLUH controls astrin-1 expression to couple mitochondrial metabolism to cell cycle progression.

Authors:  Désirée Schatton; Giada Di Pietro; Karolina Szczepanowska; Matteo Veronese; Marie-Charlotte Marx; Kristina Braunöhler; Esther Barth; Stefan Müller; Patrick Giavalisco; Thomas Langer; Aleksandra Trifunovic; Elena I Rugarli
Journal:  Elife       Date:  2022-05-13       Impact factor: 8.713

6.  SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation.

Authors:  Hongliang Liu; Junwen Hu; Ran Wei; Longfei Zhou; Hua Pan; Hongchao Zhu; Mingwen Huang; Jun Luo; Wei Xu
Journal:  J Exp Clin Cancer Res       Date:  2018-09-18

7.  Investigation of the SPAG5 gene expression and amplification related to the NuMA mRNA levels in breast ductal carcinoma.

Authors:  Zeinab Mohamadalizadeh-Hanjani; Shirin Shahbazi; Loabat Geranpayeh
Journal:  World J Surg Oncol       Date:  2020-08-24       Impact factor: 2.754
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.